BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2009945)

  • 41. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas.
    Vey N; Blaise D; Tiberghien P; Attal M; Pico JL; Reiffers J; Harrousseau JL; Fiere D; Tabilio A; Gabus R; Brandely M; Maraninchi D
    Leuk Lymphoma; 1996 Mar; 21(1-2):107-14. PubMed ID: 8907277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autologous bone marrow transplantation for non-Hodgkin lymphoma.
    Saez RA; Slease RB; Selby GB; Puckett C; Epstein RB; Mandanas RA; Confer DL
    J Okla State Med Assoc; 1994 Aug; 87(8):358-63. PubMed ID: 7931773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
    Schouten HC; Armitage JO; Klassen LW; Vaughan WP; Bierman PJ; Weisenburger D; Kessinger A
    Bone Marrow Transplant; 1989 Jan; 4(1):119-21. PubMed ID: 2466510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
    Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
    N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
    Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Demuynck HM; Link H; Zander A; Barge A
    Lancet; 1996 Feb; 347(8998):353-7. PubMed ID: 8598700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.
    Cervantes F; Shu XO; McGlave PB; Ramsay NK; Miller WJ; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1995 Sep; 16(3):387-92. PubMed ID: 8535311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The potential value of very intensive therapy with autologous bone marrow rescue in the treatment of malignant lymphomas.
    Gribben JG; Vaughan Hudson B; Linch DC
    Hematol Oncol; 1987; 5(4):281-93. PubMed ID: 3319868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
    Vose JM; Sharp G; Chan WC; Nichols C; Loh K; Inwards D; Rifkin R; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Armitage JO
    J Clin Oncol; 2002 May; 20(9):2344-52. PubMed ID: 11981006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
    Vellenga E; van Agthoven M; Croockewit AJ; Verdonck LF; Wijermans PJ; van Oers MH; Volkers CP; van Imhoff GW; Kingma T; Uyl-de Groot CA; Fibbe WE
    Br J Haematol; 2001 Aug; 114(2):319-26. PubMed ID: 11529850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autologous bone marrow transplantation in relapses of chemotherapy-sensitive aggressive non-Hodgkin's lymphoma: long-term outcome.
    Lalle M; Montuoro A
    J Chemother; 2000 Oct; 12(5):431-4. PubMed ID: 11128564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
    Bolwell BJ
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):86-95. PubMed ID: 7916488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
    Mendoza E; Territo M; Schiller G; Lill M; Kunkel L; Wolin M
    Bone Marrow Transplant; 1995 Feb; 15(2):299-303. PubMed ID: 7773222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin's lymphoma.
    Jochelson M; Tarbell NJ; Freedman AS; Rabinowe SN; Takvorian T; Soiffer R; Anderson K; Ritz J; Nadler LM
    Bone Marrow Transplant; 1990 Nov; 6(5):329-31. PubMed ID: 2291994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
    Armitage JO; Bierman PJ; Vose JM; Anderson JR; Weisenburger DD; Kessinger A; Reed EC; Vaughan WP; Coccia PF; Purtilo DT
    Am J Med; 1991 Dec; 91(6):605-11. PubMed ID: 1750430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment.
    Hurd DD; LeBien TW; Lasky LC; Haake RJ; Ramsay NK; Kim TH; Levine EG; McGlave PB; Bloomfield CD; Peterson BA
    Am J Med; 1988 Dec; 85(6):829-34. PubMed ID: 3057901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for non-Hodgkin's lymphomas: a Swedish national prospective study. Swedish Lymphoma Study Group.
    Enblad G; Hagberg H; Glimelius B
    Acta Oncol; 1996; 35(2):165-70. PubMed ID: 8639311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone marrow transplantation for non-Hodgkin's lymphoma: a review.
    Salzman DE; Briggs AD; Vaughan WP
    Am J Med Sci; 1997 Apr; 313(4):228-35. PubMed ID: 9099153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.